A formal analysis of cytokine networks in Chronic Fatigue Syndrome

Brain, Behavior, and Immunity

Volumn 24, Issue 7, 2010, Pages 1209-1217

  Broderick, Gordon ^a   Fuite, Jim ^a   Kreitz, Andrea ^a   Vernon, Suzanne D ^b   Klimas, Nancy ^c   Fletcher, Mary Ann ^d  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CFIDS Association of America   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic fatigue; Cytokines; Immune signaling; Inflammation; Latent viral infection; Network theory

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD LEVEL; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL; TH17 CELL; TH2 CELL; VIRUS INFECTION;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CYTOKINES; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKINS; KILLER CELLS, NATURAL; LYMPHOTOXIN-ALPHA; MIDDLE AGED; MODELS, IMMUNOLOGICAL; SIGNAL TRANSDUCTION; TH1 CELLS; TH17 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78049413398     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2010.04.012     Document Type: Article

References (76)

1. Aggarwal B.B., Eessalu T.E., Hass P.E. Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon. Nature 1985, 318(6047):665-667.
2. Aggarwal S., Ghilardi N., Xie M.H., de Sauvage F.J., Gurney A.L. Interleukin-23 promotes a distinct CD4Tcell activation state characterized by the production of interleukin-17. J. Biol. Chem. 2003, 278:1910-1914.
3. Airoldi I., Guglielmino R., Carra G., Corcione A., Gerosa F., Taborelli G., Trinchieri G., Pistoia V. The interleukin-12 and interleukin-12 receptor system in normal and transformed human B lymphocytes. Haematologica 2002, 87(4):434-442. (Review).
4. Aspler A.L., Bolshin C., Vernon S.D., Broderick G. Evidence of inflammatory immune signaling in chronic fatigue syndrome: a pilot study of gene expression in peripheral blood. Behav. Brain Funct. 2008, 4:44.
5. Barabási A.L. Network medicine-from obesity to the "diseasome" N. Engl. J. Med. 2007, 357(4):404-407.
6. Beirlant J., Dudewicz E., Gyorfi L., van der Meulen E. Nonparametric entropy estimation: an overview. Int. J. Math. Stat. Sci. 1997, 6(1):17-39.
7. Boniface K., Blom B., Liu Y.J., de Waal Malefyt R. From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited. Immunol. Rev. 2008, 226:132-146.
8. Bream J.H., Curiel R.E., Yu C.R., Egwuagu C.E., Grusby M.J., Aune T.M., Young H.A. IL-4 synergistically enhances both IL-2- and IL-12-induced IFN-gamma expression in murine NK cells. Blood 2003, 102(1):207-214.
9. Bunke, H., 2000. Graph matching: theoretical foundations, algorithms, and applications. In: Proc. Vision Interface 2000, Montreal, May 14-17, pp. 82-88.
10. Burke M.A., Morel B.F., Oriss T.B., Bray J., McCarthy S.A., Morel P.A. Modeling the proliferative response of T cells to IL-2 and IL-4. Cell. Immunol. 1997, 178(1):42-52.
11. Butte A.J., Kohane I.S. Mutual information relevance networks: functional genomic clustering using pairwise entropy measurements. Proc. Pac. Symp. Biocomput. 2000, 5:415-426.
12. Carlo-Stella N., Badulli C., De Silvestri A., Bazzichi L., Martinetti M., Lorusso L., Bombardieri S., Salvaneschi L., Cuccia M. A first study of cytokine genomic polymorphisms in CFS: positive association of TNF-857 and IFNgamma 874 rare alleles. Clin. Exp. Rheumatol. 2006, 24(2):179-182.
13. Chandler H.K., Ciccone D., MacBride R.J., Natelson B. Medically unexplained illness in short- and long-term disability applicants: prevalence and cost of salary reimbursement. Disabil. Rehabil. 2008, 30(16):1185-1191.
14. Cover T.M., Thomas J.A. Elements of Information Theory 2006, John Wiley & Sons, New York, 776 p.
15. Craddock R.C., Taylor R., Broderick G., Whistler T., Klimas N., Unger E.R. Exploration of statistical dependence between illness parameters using the Entropy Correlation Coefficient. Pharmacogenomics 2006, 7(3):421-428.
16. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9(1):46-56. (Review).
17. Dickinson P., Bunke H., Dadej A., Kraetzl M. Matching graphs with unique node labels. Pattern. Anal. Applic. 2004, 7:243-254.
18. Emmert-Streib F. The chronic fatigue syndrome: a comparative pathway analysis. J. Comput. Biol. 2007, 14(7):961-972.
19. Fletcher M.A., Zeng X.R., Barnes Z., Levis S., Klimas N.G. Plasma cytokines in women with chronic fatigue syndrome. J. Transl. Med. 2009, 7:96.
20. Fuite J., Vernon S.D., Broderick G. Neuroendocrine and immune network re-modeling in chronic fatigue syndrome: an exploratory analysis. Genomics 2008, 92(6):393-399.
21. Fukuda K., Straus S.E., Hickie I., Sharpe M.C., Dobbins J.G., Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann. Intern. Med. 1994, 12:953-959.
22. Gaab J., Rohleder N., Heitz V., Engert V., Schad T., Schürmeyer T.H., Ehlert U. Stress-induced changes in LPS-induced proinflammatory cytokine production in chronic fatigue syndrome. Psychoneuroendocrinology 2005, 30:188-198.
23. Gerrity T.R., Bates J., Bell D.S., Chrousos G., Furst G., Hedrick T., Hurwitz B., Kula R.W., Levine S.M., Moore R.C., Schondorf R. Chronic fatigue syndrome: what role does the autonomic nervous system play in the pathophysiology of this complex illness?. Neuroimmunomodulation 2003, 10:134-141.
24. Girvan M., Newman M.E.J. Community structure in social and biological Networks. Proc. Natl. Acad. Sci. USA 2002, 99(12):7821-7826.
25. Gu Y., Yang J., Ouyang X., Liu W., Li H., Yang J., Bromberg J., Chen S.H., Mayer L., Unkeless J.C., Xiong H. Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells. Eur. J. Immunol. 2008, 38(7):1807-1813.
26. Gupta S., Aggarwal S., See D., Starr A. Cytokine production by adherent and non-adherent mononuclear cells in chronic fatigue syndrome. J. Psychiatr. Res. 1997, 31(1):149-156.
27. Harper G., Bravi G.S., Pickett S.D., Hussain J., Green D.V. The reduced graph descriptor in virtual screening and data-driven clustering of high-throughput screening data. J. Chem. Inf. Comput. Sci. 2004, 44(6):2145-2156.
28. Hilgers A., Frank J. Chronic fatigue syndrome: immune dysfunction, role of pathogens and toxic agents and neurologic and cardial changes. Weiner Medizinische Wochenschrift 1994, 144(16):399-406.
29. Jason L.A., Benton M.C., Valentine L., Johnson A., Torres-Harding S. The economic impact of ME/CFS: individual and societal costs. Dyn. Med. 2008, 7:6.
30. Kasid A., Director E.P., Stovroff M.C., Lotze M.T., Rosenberg S.A. Cytokine regulation of tumor necrosis factor-alpha and -beta (lymphotoxin)-messenger RNA expression in human peripheral blood mononuclear cells. Cancer Res. 1990, 50(16):5072-5076.
31. Keller R.H., Lane J.L., Klimas N., Reiter W.M., Fletcher M.A., van Riel F., Morgan R. Association between HLA class II antigens and the chronic fatigue immune dysfunction syndrome. 18. Clin. Infect. Dis. 1994, 18(Suppl. 1):S154-S156.
32. Kerr J.R., Petty R., Burke B., Gough J., Fear D., Sinclair L.I., Mattey D.L., Richards S.C., Montgomery J., Baldwin D.A., Kellam P., Harrison T.J., Griffin G.E., Main J., Enlander D., Nutt D.J., Holgate S.T. Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis. J. Infect. Dis. 2008, 197(8):1171-1184.
33. Kerr J.R., Burke B., Petty R., Gough J., Fear D., Mattey D.L., Axford J.S., Dalgleish A.G., Nutt D.J. Seven genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis: a detailed analysis of gene networks and clinical phenotypes. J. Clin. Pathol. 2008, 61(6):730-739.
34. Klemm K., Bornholdt S. Topology of biological networks and reliability of information processing. Proc. Natl. Acad. Sci. USA 2005, 102(51):18414-18419.
35. Kleinberg J.M. Authoritative sources in a hyperlinked environment. J. Assoc. Comp. Mach. 1999, 46(5):604-632.
36. Klimas N., Salvato F., Morgan R., Fletcher M.A. Immunologic abnormalities in chronic fatigue syndrome. J. Clin. Microbiol. 1990, 28(6):1403-1410.
37. Laurence A., Tato C.M., Davidson T.S., Kanno Y., Chen Z., Yao Z., Blank R.B., Meylan F., Siegel R., Hennighausen L., Shevach E.M., O'shea J.J. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007, 26(3):371-381.
38. Lombardi V.C., Ruscetti F.W., Das Gupta J., Pfost M.A., Hagen K.S., Peterson D.L., Ruscetti S.K., Bagni R.K., Petrow-Sadowski C., Gold B., Dean M., Silverman R.H., Mikovits J.A. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 2009, 326(5952):585-589.
39. Louten J., Boniface K., de Waal Malefyt R. Development and function of TH17 cells in health and disease. J. Allergy Clin. Immunol. 2009, 123(5):1004-1011.
40. Maher K., Klimas N.G., Fletcher M.A. Immunology. Handbook of Chronic Fatigues 2003, 124-151. John Wiley & Sons, Hoboken. L.A. Jason, P.A. Fennell, R.R. Taylor (Eds.).
41. Maher K.J., Klimas N.G., Fletcher M.A. Chronic fatigue syndrome is associated with diminished intracellular perforin. Clin. Exp. Immunol. 2005, 142(3):505-511.
42. Margolin A.A., Wang K., Lim W.K., Kustagi M., Nemenman I., Califano A. Reverse engineering cellular networks. Nat. Protoc. 2006, 1(2):662-671.
43. Margolin A.A., Nemenman I., Basso K., Wiggins C., Stolovitzky G., Dalla Favera R., Califano A. ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. BMC Bioinf. 2006, 7(Suppl. 1):S7.
44. McGeachy M.J., Bak-Jensen K.S., Chen Y., Tato C.M., Blumenschein W., McClanahan T., Cua D.J. TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell-mediated pathology. Nat. Immunol. 2007, 8:1390-1397.
45. Milo, R., Kashtan, N., Itzkowitz, S., Newman, M.E.J., Alon, U., 2004. On the uniform generation of random graphs with prescribed degree sequences. Available from: http://arxiv.org/pdf/cond-mat/0312028.
46. Newman M.E.J. Detecting Community Structure in Networks. Eur. Phys. J. B 2004, 38(2):321-330.
47. Newman M.E.J. Analysis of weighted graphs. Phys. Rev. E 2004, 70(5):56131-1-56131-9.
48. Newman M.E.J., Girvan M. Finding and evaluating community structure in networks. Phys. Rev. E 2004, 69(2):026113(15).
49. Newman M.E.J. Modularity and community structure in networks. Proc. Natl. Acad. Sci. USA 2006, 103(23):8577-8582.
50. Newman M.E.J. Finding community structure in networks using the eigenvectors of matrices. Phys. Rev. E 2006, 74(3):036104(19).
51. Orosz C.G. An introduction to immuno-ecology and immuno-informatics. Design Principles for the Immune System and Other Distributed Autonomous Systems 2001, 125-149. Oxford University Press, New York. L.A. Segel, I.R. Cohen (Eds.).
52. Patarca R., Fletcher M.A., Podack E. Cytolytic cell functions. Manual of Clinical Laboratory Immunology 1997, 296-303. ASM Press, Washington. N. Rose, E. deMacario, J. Folds, H.C. Lane, R. Nakamura (Eds.).
53. Patarca-Montero R., Antoni M., Fletcher M.A., Klimas N.G. Cytokine and other immunologic markers in chronic fatigue syndrome and their relation to neuropsychological factors. Appl. Neuropsychol. 2001, 8(1):51-64.
54. Pemmaraju S., Skiena S. Computational Discrete Mathematics: Combinatorics and Graph Theory with Mathematica® 2003, Cambridge University Press, Cambridge & New York, pp. 220-223.
55. Perona-Wright G., Jenkins S.J., O'Connor R.A., Zienkiewicz D., McSorley H.J., Maizels R.M., Anderton S.M., MacDonald A.S. A pivotal role for CD40-mediated IL-6 production by dendritic cells during IL-17 induction in vivo. J. Immunol. 2009, 182(5):2808-2815.
56. Prins J., van der Meer J., Bleijenberg G. Chronic Fatigue Syndrome. Lancet 2006, 367(9507):346-355.
57. Reeves W.C., Lloyd A., Vernon S.D., Klimas N., Jason L.A., Bleijenberg G., Evengard B., White P.D., Nisenbaum R., Unger E.R. Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Serv. Res. 2003, 3(1):25. International Chronic Fatigue Syndrome Study Group, (Review).
58. Reeves W.C., Jones J.F., Maloney E., Heim C., Hoaglin D.C., Boneva R.S., Morrissey M., Devlin R. Prevalence of chronic fatigue syndrome in metropolitan, urban, and rural Georgia. Popul. Health Metr. 2007, 5:5.
59. Reynolds K.J., Vernon S.D., Bouchery E., Reeves W.C. The economic impact of chronic fatigue syndrome. Cost Eff. Resour. Alloc. 2004, 2(1):4.
60. Ruhnau B. Eigenvector-centrality-a Node Centrality?. Soc. Netw. 2000, 22:357-365.
61. Saghafian-Hedengren S., Sundström Y., Sohlberg E., Nilsson C., Linde A., Troye-Blomberg M., Berg L., Sverremark-Ekström E. Herpesvirus seropositivity in childhood associates with decreased monocyte-induced NK cell IFN-gamma production. J. Immunol. 2009, 182(4):2511-2517.
62. Samanta M., Iwakiri D., Takada K. Epstein-Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling. Oncogene 2008, 27(30):4150-4160.
63. Samanta, M., Takada, K., 2009. Modulation of innate immunity system by Epstein-Barr virus-encoded non-coding RNA and oncogenesis. Cancer Sci. Sep 29. [Epub ahead of print].
64. Siegel S.D., Antoni M.H., Fletcher M.A., Maher K., Segota M.C., Klimas N. Impaired natural immunity, cognitive dysfunction, and physical symptoms in patients with chronic fatigue syndrome: preliminary evidence for a subgroup?. J. Psychosom. Res. 2006, 60:559-566.
65. Skowera A., Cleare A., Blair D., Bevis L., Wessely S.C., Peakman M. High levels of type 2 cytokine-producing cells in chronic fatigue syndrome. Clin. Exp. Immunol. 2004, 135(2):294-302.
66. Straus S.E., Fritz S., Dale J.K., Gould B., Strober W. Lymphocyte phenotyping and function in chronic fatigue syndrome. J. Clin. Immunol. 1993, 13(1):30-40.
67. Szymańska E., Markuszewski M.J., Capron X., van Nederkassel A.M., Heyden Y.V., Markuszewski M., Krajka K., Kaliszan R. Increasing conclusiveness of metabonomic studies by chem-informatic preprocessing of capillary electrophoretic data on urinary nucleoside profiles. J. Pharm. Biomed. Anal. 2007, 43(2):413-420.
68. ter Wolbeek M., van Doornen L.J., Kavelaars A., van de Putte E.M., Schedlowski M., Heijnen C.J. Longitudinal analysis of pro- and anti-inflammatory cytokine production in severely fatigued adolescents. Brain Behav. Immun. 2007, 21(8):1063-1074.
69. Thompson M.P., Aggarwal B.B., Shishodia S., Estrov Z., Kurzrock R. Autocrine lymphotoxin production in Epstein-Barr virus-immortalized B cells: induction via NF-kappaB activation mediated by EBV-derived latent membrane protein 1. Leukemia 2003, 17(11):2196-2201.
70. Tirelli U., Bernardi D., Improta S., Pinto A. Immunologic abnormalities in chronic fatigue syndrome. J. Chronic Fatigue Syndrome 1996, 2(1):85-96.
71. Tsai S.C., Lin S.J., Chen P.W., Luo W.Y., Yeh T.H., Wang H.W., Chen C.J., Tsai C.H. EBV Zta protein induces the expression of interleukin-13, promoting the proliferation of EBV-infected B cells and lymphoblastoid cell lines. Blood 2009, 114(1):109-118.
72. Tsuge I., Morishima T., Kimura H., Kuzushima K., Matsuoka H. Impaired cytotoxic T lymphocyte response to Epstein-Barr virus-infected NK cells in patients with severe chronic active EBV infection. J. Med. Virol. 2001, 64(2):141-148.
73. Vollmer-Conna U., Aslakson E., White P.D. An empirical delineation of the heterogeneity of chronic unexplained fatigue in women. Pharmacogenomics 2006, 7(3):355-364.
74. Wang K.S., Frank D.A., Ritz J. Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4. Blood 2000, 95(10):3183-3190.
75. Wilson A.D., Hopkins J.C., Morgan A.J. In vitro cytokine production and growth inhibition of lymphoblastoid cell lines by CD41 T cells from Epstein-Barr virus (EBV) seropositive donors. Clin. Exp. Immunol. 2001, 126:101-110.
76. World Health Organization, 1997. Composite Interview Diagnostic Interview (CIDI core), version 2.1.